Jad I Belle

7PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2024
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression.

Jiayu Ye, John M Baer, Douglas V Faget

|Apr 29, 2024
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.

Jad I Belle, Devashish Sen, John M Baer

|Jun 07, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer.

Brett H Herzog, John M Baer, Nicholas Borcherding

|Mar 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.

Chong Zuo, John M Baer, Brett L Knolhoff

|Oct 13, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

|Sep 27, 2022
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade.

Varintra E Lander, Jad I Belle, Natalie L Kingston

Pageof 2

Frequent Collaborators

6 joint publications

David G DeNardo

4 joint publications

Brett L Knolhoff

4 joint publications

John M Baer

3 joint publications

Varintra E Lander